Yale Engage
Yale ENGAGE Series
Copy Link
Defining Mechanisms and Biomarkers of Sensitivity & Resistance To Anti-Cancer Treatments
December 9, 2020
Corporate Guest Speaker: Susan Galbraith, PhD, Senior Vice President and Head of Early Oncology R&D, AstraZeneca Panelists from Yale: Megan King, PhD, Mark Lemmon, PhD, Katerina Politi, PhD, Kurt Schalper, MD, PhD, and Qin Yan, PhD
Immuno-Oncology
October 21, 2020
Presentations from Yale by Marcus Bosenberg, MD, PhD, Grace Chen, PhD, Roy Herbst, MD, PhD, Akiko Iwasaki, PhD, and Aaron Ring, MD, PhD
Novel Therapeutics & Delivery Systems
November 5, 2020
Corporate Guest: Josh Bilenker, CEO of Loxo Oncology at Lilly Panelists from Yale: Ranjit Bindra, MD, PhD, Sidi Chen, PhD, Craig Crews, PhD, and Faye Rogers, PhD